http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2576834-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f48cc888734096f4e34dcc05a8df99f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e17a9fe8ae81a09478a814ec5ef3177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d394bb6a7044b4c7d2400ddb8a56152 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
filingDate | 2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69f6d91ee2804fc6366e2e906f955827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12cf4ee647332a56313949fa2b6b0ae1 |
publicationDate | 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2576834-C2 |
titleOfInvention | Method of treating eczema |
abstract | FIELD: medicine. n SUBSTANCE: invention concerns a method of treating eczema, characterised by the fact that a routine therapeutic approach is added by coating the involved skin area with 0.1% tacrolimus for 1 month in the morning and evening, and then for 2 months, once before bedtime; when using tacrolimus, applying any other agents on the skin area coated with tacrolimus and taking water procedures shall be avoided. n EFFECT: invention enables reducing or eliminating the risk of side effects and tachyphylaxis, and prolonging the remission. n 2 ex |
priorityDate | 2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.